Analysis of protooncogene c-erbB-2 in benign and malignant human prostate

International Urology and Nephrology

Volumn 31, Issue 1, 1999, Pages 61-73

  Watanabe, M ^a   Nakada, T ^a   Yuta, H ^b  

^a YAMAGATA UNIVERSITY   (Japan)

^b Yamagata City Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MESSENGER RNA; MONOCLONAL ANTIBODY;

ANTIGENICITY; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; GENE REARRANGEMENT; GENOME; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; PROTO ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BLOTTING, SOUTHERN; GENE EXPRESSION; GENES, ERBB-2; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS; RECEPTOR, ERBB-2; TUMOR CELLS, CULTURED;

EID: 0033055188     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007123807244     Document Type: Article

References (33)

1. Yamamoto, T., Ikawa, S., Akiyama, T., Semba, K., Nomura, N., Miyajima, N., Saito, T., Toyoshima, K.: Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor. Nature. 319, 230 (1986).
2. Mori, S., Akiyama, T., Yamada, Y., Morishita, Y., Sugawara, I., Toyoshima, K., Yamamoto, T.: C-erbB-2 gene product, a membrane protein commonly expressed on human fetal epithelial cells. Lab. Invest., 61, 93 (1989).
3. Bergmann, C. I., Hung, M.-C., Weinberg, R. A.: The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature, 319, 226 (1986).
4. Bergmann, C. I., Hung, M.-C., Weinberg, R. A.: Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell, 45, 649 (1986).
5. Bouchard, L., Lamarre, L., Tremblay, P. J., Jolicoeur, P.: Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene. Cell, 57, 931 (1989).
6. Suda, Y., Aizawa, S., Furuta, Y., Yagi, T., Ikawa, Y., Saitoh, K., Yamada, Y., Toyoshima, K., Yamamoto, T.: Induction of a variety of tumors by c-erbB-2 and clonal nature of lymphomas even with the mutated gene (Val659-Glu659). EMBO J., 9, 181 (1990).
7. Yokota, J., Yamamoto, T., Toyoshima, K., Terada, M., Sugiura, T., Battifora, H., Cline, M. J.: Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo. Lancet, I, 765 (1986).
8. Slamon, D. J., Goldphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., Press, M. F.: Studies of the HER-2/neu protooncogene in human breast and ovarian cancer. Science, 244, 707 (1989).
9. Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., McGuire, W. L.: Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science, 235, 177 (1987).
10. Berchuck, A., Kamel, A., Whitaker, R., Lerns, B., Olt, G., Kinney, R., Soper, J., Dodge, R., Clarke-Pearson, D. L., Marks, P., McKenzie, S., Yin, S., R. C. Bast, J.: Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer. Cancer Res., 50, 4087 (1990).
11. Yoneyama, Y., Ninomiya, I., Yamaguchi, A., Fushida, S., Kimura, H., Ohoyama, S., Miyazaki, I., Endou, Y., Endo, M., Sasaki, T.: Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer. Cancer Res., 51, 1034 (1991).
12. Arai, Y., Yoshiki, T., Yoshida, O.: c-erbB-2 oncoprotein: A potential biomarker of advanced prostate cancer. Prostate, 30, 195 (1997).
13. Saga, T., Endo, K., Akiyama, T., Sakahara, H., Koizumi, M., Watanabe, Y., Nakai, T., Hosono, M., Yamamoto, T., Toyoshima, K.: Scintigraphic detection of overexpressed c-erbB-2 protooncogene products by a class-switched murine anti-c-erbB-2 protein monoclonal antibody. Cancer Res., 51, 990 (1991).
14. Tai, M. S., McCartney, J. E., Adams, G. P., Jin, D., Hudziak, R. M., Oppermann, H., Laminet, A. A., Bookman, M. A., Wolf, E. J., Liu, S.: Targeting c-erbB-2 expressing tumors using single-chain Fv monomers and dimers. Cancer Res., 55, 5983 (1995).
15. Keler, T., Graziano, R. F., Mandal, A., Wallace, P. K., Fisher, J., Guyre, P. M., Fanger, M. W., Deo, Y. M.: Bispecific antibody-dependent cellular cytotoxicity of HER2/neuoverexpressing tumor cells by Fc gamma receptor type I-expressing effector cells. Cancer Res., 57, 4008 (1997).
16. Nagata, Y., Furugen, R., Hiasa, A., Ikeda, H., Ohta, N., Furukawa, K., Nakamura, H., Furukawa, K., Kanematsu, T., Shiku, H.: Peptides derived from a wild-type murine proto-oncogene c-erbB-2/HER2/neu can induce CTL and tumor suppression in syngeneic hosts. J. Immunol., 159, 1336 (1997).
17. Lustgarten, J., Theobald, M., Labadie, C., LaFace, D., Peterson, P., Disis, M. L., Cheever, M. A., Sherman, L. A.: Identification of Her-2/Neu CTL epitopes using double transgenic mice expressing HLA-A2.1 and human CD.8. Hum. Immunol., 52, 109 (1997).
18. Lalani el, N., Laniado, M. E., Abel, P. D.: Molecular and cellular biology of prostate cancer. Cancer Metastasis Rev., 16, 29 (1997).
19. Sambrook, J., Fritsch, E. F., Maniatis, T.: Molecular Cloning. A Laboratory Manual. 2, 9, 16 (1989).
20. Chomozynski, P., Sacchi, N.: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156 (1987).
21. Ross, J. S., Nazeer, T., Church, K., Amato, C., Figge, H., Rifkin, M. D., Fisher, H. A.: Contribution of HER-2/neu oncogene expression to tumor grade and DNA content analysis in the prediction of prostatic carcinoma metastasis. Cancer, 72, 3020 (1993).
22. Giri, D. K., Wadhwa, S. N., Upadhaya, S. N., Talwar, G. P.: Expression of NEU/HER-2 oncoprotein (p185neu) in prostate tumors: An immunohistochemical study. Prostate, 23, 329 (1993).
23. Ware, J. L., Maygarden, S. J., Koontz, W. J., Strom, S. C.: Immunohistochemical detection of c-erbB-2 protein in human benign and neoplastic prostate. Hum. Pathol., 22, 254 (1991).
24. Mellon, K., Thompson, S., Charlton, R. G., Marsh, C., Robinson, M., Lane, D. P., Harris, A. L., Horne, C. H., Neal, D. E.: p53, c-erbB-2 and the epidermal growth factor receptor in the benign and malignant prostate. J. Urol., 147, 496 (1992).
25. Kuhn, E. J., Kurnot, R. A., Sesterhenn, I. A., Chang, E. H., Moul, J. W.: Expression of the c-erbB-2 (HER-2/neu) oncoprotein in human prostatic carcinoma. J. Urol., 150, 1427 (1993).
26. Sikes, R. A., Chung, L. W.: Acquisition of a tumorigenic phenotype by a rat ventral prostate epithelial cell line expressing a transfected activated neu oncogene. Cancer Res., 52, 3174 (1992).
27. Drebin, J. A., Link, V. C., Greene, M. I.: Monoclonal antibodies reactive with distinct domains of the neu oncogene-encoded p185 molecule exert synergistic anti-tumor effects in vivo. Oncogene, 2, 273 (1988).
28. Drebin, J. A., Link, V. C., Stern, D. F., Weinberg, R. A., Greene, M. I.: Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies. Cell, 41, 697 (1985).
29. Grasso, A. W., Wen, D., Miller, C. M., Rhim, J. S., Pretlow, T. G., Kung, H. J.: ErbB kinases and NDF signaling in human prostate cancer cells. Oncogene, 15, 2705 (1997).
30. Mori, S., Akiyama, T., Morishita, Y., Shimizu, S., Sakai, K., Sudoh, K., Toyoshima, K., Yamamoto, T.: Light and electron microscopical demonstration of c-erbB-2 gene product-like immunoreactivity in human malignant tumors. Virchows Arch. [B] Cell. Pathol., 54, 8 (1987).
31. Kokai, Y., Cohen, J. A., Drebin, J. A., Greene, M. I.: Stage- and tissue-specific expression of the neu oncogene in rat development. Proc. Natl Acad. Sci USA, 84, 8498 (1987).
32. Lemoine, N. R., Staddon, S., Dickson, C., Barnes, D. M., Gullick, W. J.: Absence of activating transmembrane mutations in the c-erbB-2 proto-oncogene in human breast cancer. Oncogene, 5, 237 (1990).
33. Papewalis, J., Nikitin, A., Rajewsky, M. F.: G to A polymorphism at amino acid codon 655 of the human erbB-2/HER2 gene. Nucleic Acids Res., 19, 5452 (1991).